Vanguard Group’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.06M | Buy |
|
|||||
|
2025
Q2 | $2.72M | Buy |
|
|||||
|
2025
Q1 | $1.95M | Hold |
|
|||||
|
2024
Q4 | $1.77M | Hold |
|
|||||
|
2024
Q3 | $2.92M | Hold |
|
|||||
|
2024
Q2 | $1.37M | Hold |
|
|||||
|
2024
Q1 | $1.85M | Hold |
|
|||||
|
2023
Q4 | $2.16M | Hold |
|
|||||
|
2023
Q3 | $3.67M | Hold |
|
|||||
|
2023
Q2 | $7M | Sell |
|
|||||
|
2023
Q1 | $6.59M | Hold |
|
|||||
|
2022
Q4 | $3.03M | Buy |
|
|||||
|
2022
Q3 | $2.66M | Hold |
|
|||||
|
2022
Q2 | $4.28M | Sell |
|
|||||
|
2022
Q1 | $7M | Sell |
|
|||||
|
2021
Q4 | $9.26M | Buy |
|
|||||
|
2021
Q3 | $15.2M | Sell |
|
|||||
|
2021
Q2 | $15.9M | Buy |
|
|||||
|
2021
Q1 | $18.2M | Sell |
|
|||||
|
2020
Q4 | $17.7M | Buy |
|
|||||
|
2020
Q3 | $15.1M | Buy |
|
|||||
|
2020
Q2 | $15.8M | Buy |
|
|||||
|
2020
Q1 | $10.9M | Buy |
|
|||||
|
2019
Q4 | $5.41M | Sell |
|
|||||
|
2019
Q3 | $7.09M | Buy |
|
|||||
|
2019
Q2 | $9.09M | Buy |
|
|||||
|
2019
Q1 | $10.4M | Buy |
|
|||||
|
2018
Q4 | $10.5M | Buy |
|
|||||
|
2018
Q3 | $15.8M | Sell |
|
|||||
|
2018
Q2 | $14.3M | Buy |
|
|||||
|
2018
Q1 | $7.04M | Buy |
|
|||||
|
2017
Q4 | $5.54M | Buy |
|
|||||
|
2017
Q3 | $4.96M | Buy |
|
|||||
|
2017
Q2 | $1.94M | Sell |
|
|||||
|
2017
Q1 | $2.55M | Buy |
|
|||||
|
2016
Q4 | $2.98M | Sell |
|
|||||
|
2016
Q3 | $3.57M | Buy |
|
|||||
|
2016
Q2 | $2.45M | Buy |
|
|||||
|
2016
Q1 | $2.09M | Buy |
|
|||||
|
2015
Q4 | $2.83M | Buy |
|
|||||
|
2015
Q3 | $3.1M | Buy |
|
|||||
|
2015
Q2 | $2.93M | Buy |
|
|||||
|
2015
Q1 | $3.27M | Buy |
|